VMD · Viemed Healthcare, Inc.
$9.20
+0.03 (+0.33%)
At close · Aug 14
Market Cap
$350.41M
Shares
38.09M
Viemed Healthcare, Inc. Earnings Call Transcripts
Every quarterly earnings call for Viemed Healthcare, Inc. (VMD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲22.1%
$35.76M
$1.05M
'22 Q3
22-11-01
▲17.4%
$37.51M
$2.44M
'22 Q4
23-03-02
▲22.6%
$39.56M
$1.52M
'23 Q1
23-05-08
▲30%
$43.31M
$2.33M
'23 Q2
23-08-09
▲38.2%
$49.40M
$2.92M
'23 Q3
23-11-01
▲35.3%
$50.74M
$3.48M
'23 Q4
24-03-06
▲27.9%
$50.59M
$1.60M
'24 Q1
24-05-06
▲26.9%
$54.97M
$1.47M
'24 Q2
24-08-07
▲17.4%
$58.00M
$3.88M
'24 Q3
24-11-06
▲19.6%
$60.70M
$4.32M
'24 Q4
25-03-10
▲16.9%
$59.13M
$2.62M
'25 Q1
25-05-07
▲14.7%
$63.06M
$3.16M
'25 Q2
25-08-06
▲24%
$71.91M
$3.51M
'25 Q3
25-11-05
▲25.5%
$76.18M
$5.64M
'25 Q4
26-03-05
▲27.5%
$75.41M
$2.58M
'26 Q1
26-05-06
LATEST
▲23.9%
$78.10M
$2.76M
'26 Q2
26-08-04
Earnings call
FY26 · Q2
2026-08-04
Viemed Healthcare, Inc. Q2 FY2026 Earnings Call
Confident tone
Ventilation growth under new CMS NCD framework
Compliance and clinical engagement
Maternal health / LeeHand integration
Revenue
$78.10M
▲ 23.9% YoY Diluted EPS
$0.07
▼ 12.5% YoY Gross margin
57.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Viemed Healthcare, Inc. Q1 FY2026 Earnings Call
Confident tone
Ventilation NCD dynamics
Sleep / PAP therapy growth
Financial performance and free cash flow
Revenue
$75.41M
▲ 27.5% YoY Diluted EPS
$0.06
▲ 0% YoY Gross margin
56.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
Viemed Healthcare, Inc. Q4 FY2025 Earnings Call
Confident tone
NCD transition and ventilators
Sleep and resupply growth
Regulatory environment and competitive bidding
Revenue
$76.18M*
▲ 25.5% YoY Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Viemed Healthcare, Inc. Q3 FY2025 Earnings Call
Confident tone
Sleep Therapy and Resupply Growth
Lehan's Medical Equipment Acquisition and Integration
Respiratory/Ventilation Core Business
Revenue
$71.91M
▲ 24% YoY Diluted EPS
$0.09
▼ 10% YoY Gross margin
57.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Viemed Healthcare, Inc. Q2 FY2025 Earnings Call
Confident tone
Competitive bidding risk
Core ventilation growth
Capital allocation and margins
Revenue
$63.06M
▲ 14.7% YoY Diluted EPS
$0.08
▲ 100% YoY Gross margin
58.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Viemed Healthcare, Inc. Q1 FY2025 Earnings Call
Confident tone
Regulatory and Reimbursement Environment
Lehan's Medical Equipment Acquisition
First Quarter Operational Performance
Revenue
$59.13M
▲ 16.9% YoY Diluted EPS
$0.06
▲ 50% YoY Gross margin
56.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-10
Viemed Healthcare, Inc. Q4 FY2024 Earnings Call
Confident tone
Behavioral health opportunity
Cash flow outlook
In-home care trend
Revenue
$60.70M*
▲ 19.6% YoY Gross margin
59.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Viemed Healthcare, Inc. Q3 FY2024 Earnings Call
Confident tone
Core vent business growth
Philips ventilator recall replacement / CapEx
Sleep business and GLP-1 impact
Revenue
$58.00M
▲ 17.4% YoY Diluted EPS
$0.10
▲ 42.9% YoY Gross margin
59.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Viemed Healthcare, Inc. Q2 FY2024 Earnings Call
Confident tone
Philips ventilator buyback and fleet refresh
Organic revenue growth and core ventilator business
Sleep / CPAP business and GLP-1 dynamics
Revenue
$54.97M
▲ 26.9% YoY Diluted EPS
$0.04
▼ 33.3% YoY Gross margin
59.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Viemed Healthcare, Inc. Q1 FY2024 Earnings Call
Confident tone
Sleep Apnea Market Growth
Change Healthcare Disruption
Hospital Joint Ventures and HMP Integration
Revenue
$50.59M
▲ 27.9% YoY Diluted EPS
$0.04
▲ 0% YoY Gross margin
58.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-06
Viemed Healthcare, Inc. Q4 FY2023 Earnings Call
Confident tone
CMS final rules on managed care
HMP acquisition and inorganic growth
Regulatory and reimbursement environment
Revenue
$50.74M*
▲ 35.3% YoY Gross margin
63.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Viemed Healthcare, Inc. Q3 FY2023 Earnings Call
Revenue
$49.40M
▲ 38.2% YoY Diluted EPS
$0.07
▲ 133.3% YoY Gross margin
61.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Viemed Healthcare, Inc. Q2 FY2023 Earnings Call
Revenue
$43.31M
▲ 30% YoY Diluted EPS
$0.06
▲ 200% YoY Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Viemed Healthcare, Inc. Q1 FY2023 Earnings Call
Revenue
$39.56M
▲ 22.6% YoY Diluted EPS
$0.04
▲ 0% YoY Gross margin
60.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-02
Viemed Healthcare, Inc. Q4 FY2022 Earnings Call
Revenue
$37.51M*
▲ 17.4% YoY Gross margin
61.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Viemed Healthcare, Inc. Q3 FY2022 Earnings Call
Revenue
$35.76M
▲ 22.1% YoY Diluted EPS
$0.03
▼ 25% YoY Gross margin
60.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Viemed Healthcare, Inc. Q2 FY2022 Earnings Call
Revenue
$33.31M
▲ 21.6% YoY Diluted EPS
$0.02
▼ 50% YoY Gross margin
61.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-05-04
Viemed Healthcare, Inc. Q4 FY2021 Earnings Call
Revenue
$31.96M*
▲ 2.4% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q1
2022-05-03
Viemed Healthcare, Inc. Q1 FY2022 Earnings Call
Revenue
$32.26M
▲ 13.5% YoY Diluted EPS
$0.04
▲ 0% YoY Gross margin
61.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q3
2021-11-02
Viemed Healthcare, Inc. Q3 FY2021 Earnings Call
Revenue
$29.29M
▼ 12.4% YoY Diluted EPS
$0.04
▼ 42.9% YoY Gross margin
62.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-02
Viemed Healthcare, Inc. Q2 FY2021 Earnings Call
Revenue
$27.40M
▼ 36.1% YoY Diluted EPS
$0.04
▼ 91.7% YoY Gross margin
64.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-03
Viemed Healthcare, Inc. Q1 FY2021 Earnings Call
Revenue
$28.42M
▲ 19.4% YoY Diluted EPS
$0.04
▼ 63.6% YoY Gross margin
62.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-03
Viemed Healthcare, Inc. Q4 FY2020 Earnings Call
Revenue
$31.20M
▲ 45.5% YoY Diluted EPS
$0.12
▲ 100% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Viemed Healthcare, Inc. Q3 FY2020 Earnings Call
Revenue
$33.45M
▲ 64.2% YoY Diluted EPS
$0.07
▲ 0% YoY Gross margin
58.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Viemed Healthcare, Inc. Q2 FY2020 Earnings Call
Revenue
$42.85M
▲ 110.8% YoY Diluted EPS
$0.48
▲ 1500% YoY Gross margin
60.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-04
Viemed Healthcare, Inc. Q1 FY2020 Earnings Call
Revenue
$23.81M
▲ 31.4% YoY Diluted EPS
$0.11
▲ 120% YoY Gross margin
65.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-03
Viemed Healthcare, Inc. Q4 FY2019 Earnings Call
Revenue
$21.45M
▲ 16.8% YoY Diluted EPS
$0.06
▼ 14.3% YoY Gross margin
66.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
1729149
CUSIP
92663R105
13F (30d)
156 filings
150 filers
Visit website
Investor relations